Pay in 4 interest-free payments of $5.86 Learn more
Ships within 48 hours · Estimated delivery Sep 28 - Oct 3
Janelle Duah is an ABMS board certified Internal Medicine Physician specializing in Primary Care and Obesity Medicine
Benefits (Research Focus) GLP-1 receptor agonism studied for selective activation of the GLP-1 receptor with downstream insulin and glucagon regulation Glycemic control research investigated for fasting glucose, HbA1c, and insulin sensitivity parameters in T2D models Body composition examined for fat-mass and lean-mass partitioning in DIO and obesity models Appetite and gastric pathways explored for satiety signaling and delayed gastric emptying endpoints Long-acting profile C18 fatty diacid albumin-binding chemistry for extended half-life (~7 days) What Researchers Look At GLP-1 receptor binding affinity, cAMP activation, and -arrestin recruitment Food intake, body weight, and adipose-tissue change in DIO rodent models Pancreatic -cell function and insulinotropic response endpoints Gastric emptying time and gastrointestinal transit profiles Comparative pharmacology versus tirzepatide, retatrutide, and other incretin analogs Quick Specs Form: Lyophilized white powder Net Peptide Content: 10 mg per vial Quantity: 1 vial Appearance: White to off-white lyophilizate Reconstitution: Bacteriostatic or sterile water (added by the end researcher) Purity: 99% by HPLC Identity: MS-verified (per COA) Storage: Protect from light Identity Basics Compound: Semaglutide Synonyms: NN9535
Energy crashes
According to the National Institutes of Health, though most individuals do not need to make an extra effort to eat foods high in carnitine , some genetic or medical problems (such as angina or intermittent claudication) and certain drugs can prevent the body from producing enough of the nutrient, resulting in a shortage
